- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06643806
Implementation of a Peer Leader-facilitated Dyadic Intervention
Implementation of a Peer Leader-facilitated Dyadic Intervention to Decrease Cardiovascular Disease Risk Among First Generation Asian Indian Immigrants
Study Overview
Status
Intervention / Treatment
Detailed Description
Asian Indian (AI) immigrants, the second largest immigrant group in the US, have a high prevalence of abdominal obesity and premature cardiovascular disease (CVD). Despite ample epidemiological evidence of the need to reduce CVD risk in AIs, few published interventions have addressed this population, primarily focusing on dietary measures and promotion of physical activity, and none of these address immigrant AIs.
This Pilot Study Large Application builds upon the results of our prior work to 1) Implement and pilot test a peer leader-facilitated 12-week dyadic intervention (Community Health among Asian Indian immigrants (CHAI) Dyad study) using a cluster randomization design, to decrease CVD risk among first generation AI immigrants; and 2) Assess the feasibility/acceptability of a full-scale intervention. Twenty marital dyads from the site randomly assigned as the intervention site will receive the 12- week peer leader-facilitated dyadic intervention, while 20 dyads from the site randomly assigned as the "usual care" control group site will receive a basic cardiovascular lifestyle modification program. Both groups will meet weekly (90 min. classes) for 12 weeks in a hybrid format (a combination of face to face and remote learning). The intervention is designed to address factors that we identified in our previous study as contributing to a syndemic of cardiovascular disease among AI immigrants including acculturation stress, family history and genetic risk, physical inactivity, as well as a high fat, high-carbohydrate, high-calorie diet.
Unlike a hypothesis generating study, a pilot study is designed to assess the feasibility/accessibility of an approach to be used in a larger scale study. The following research questions are designed to address feasibility and accessibility of this pilot cluster randomized controlled trial intervention:
Q1 Can the target population of AI immigrant dyads be recruited from faith-based or AI community-based organizations in Central and Northern NJ? Q2 Can the target population of AI immigrant dyads be randomized in a cluster randomized controlled trial? Q3 Can the target population of AI immigrant dyads be retained? Q4 Can the treatments be delivered per protocol? Q5 Will AI immigrant dyads adhere to the treatment protocol? Q6 Are the treatment conditions of the intervention acceptable to AI immigrant dyads?
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karen T D'Alonzo, PhD
- Phone Number: (908)-963-7064
- Email: kdalonzo@sn.rutgers.edu
Study Contact Backup
- Name: Shailja Mathur, M.S., M.Ed.,
- Phone Number: 908-692-5823
- Email: mathur@njaes.rutgers.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- community-dwelling first generation Asian Indian (AI) immigrants (in marital dyads) between the ages of 18-70 years of age who can read and write English and are technology literate.
Exclusion Criteria:
- AIs not in a marital dyad, those below the age of 20 or above 70 years or those born in the US or visiting the US from India.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Twenty marital dyads from the site randomly assigned as the intervention site(s) will receive the 12- week peer leader-facilitated dyadic intervention.
Topics over the 12 week intervention will address stress management, family history and genetic risk, dietary habits, physical activity and social support/community engagement.
|
In the CHAI (Cardiovascular Health among Asian Indian immigrants) Dyad study, we plan to Implement and pilot test a peer leader-facilitated 12-week dyadic intervention to decrease CVD risk among first generation AI immigrants;
|
|
Active Comparator: Control
Twenty dyads from the site randomly assigned as the "usual care" control group site will receive a basic cardiovascular lifestyle modification program.
This program will be similar to a classic cardiac rehabilitation program and will consist of diet, physical activity and medical management.
|
In the CHAI (Cardiovascular Health among Asian Indian immigrants) Dyad study, we plan to Implement and pilot test a peer leader-facilitated 12-week dyadic intervention to decrease CVD risk among first generation AI immigrants;
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk of CVD
Time Frame: 13 weeks
|
Measured by the QRISK3
|
13 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acculturation stress
Time Frame: 13 weeks
|
Measured by the Riverside Acculturation Stress Inventory
|
13 weeks
|
|
Perceived stress
Time Frame: 13 weeks
|
Measured by the Perceived Stress Scale
|
13 weeks
|
|
Body composition
Time Frame: 13 weeks
|
BMI (weight and height will be combined to report BMI in kg/m^2)
|
13 weeks
|
|
waist circumference
Time Frame: 13 weeks
|
Body composition
|
13 weeks
|
|
Hemoglobin A1c
Time Frame: 13 weeks
|
Measure of glucose control
|
13 weeks
|
|
Lipid panel
Time Frame: 13 weeks
|
Total cholesterol, HDL, LDL, triglycerides
|
13 weeks
|
|
Inflammation
Time Frame: 13 weeks
|
C-reactive protein
|
13 weeks
|
|
Genetic risk of CVD
Time Frame: 13 weeks
|
Lipoprotein a
|
13 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Community support
Time Frame: 13 weeks
|
Perceived community support questionnaire
|
13 weeks
|
|
Salivary cortisol
Time Frame: 13 weeks
|
three specimens (upon rising, one-half hour later and at bedtime)
|
13 weeks
|
|
Physical activity
Time Frame: 13 weeks
|
NASA JSC physical activity scale
|
13 weeks
|
|
dietary intake
Time Frame: 13 weeks
|
3 day dietary diary
|
13 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Karen T D'Alonzo, PhD, Rutgers, The State University of New Jersey
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2024002046
- 1P50MD017356-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on CHAI dyad study
-
University of MinnesotaWithdrawnChronic Stroke
-
Copenhagen Academy for Medical Education and SimulationJohnson & Johnson; Danish Council for Independent ResearchUnknown
-
Clevr BlendsCitruslabsCompletedSleep | Anxiety | Mood | Caffeine Withdrawal | ProductivityUnited States
-
Taipei Medical UniversityCompleted
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedObesity | Cardiovascular Disease | Cancer | Type II Diabetes | Peer Support and Chronic DiseaseUnited States
-
University of PennsylvaniaCompletedMental Health Wellness 1 | LonelinessUnited States
-
Icahn School of Medicine at Mount SinaiCompletedOther Preterm InfantsUnited States
-
Rigshospitalet, DenmarkUniversity of CopenhagenCompletedLearning Outcome | Training EfficiencyDenmark
-
Medical University of South CarolinaCompleted
-
Gia MuddNational Institute of Nursing Research (NINR)CompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States